Rankings
▼
Calendar
PRME Q2 2023 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena
PRME
Prime Medicine, Inc.
$771M
Q2 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$45M
Net Income
-$42M
EPS (Diluted)
$-0.47
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$41M
Free Cash Flow
-$43M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$281M
Total Liabilities
$41M
Stockholders' Equity
$240M
Cash & Equivalents
$121M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$45M
-$26M
-72.0%
Net Income
-$42M
-$29M
-44.4%
← FY 2023
All Quarters
Q3 2023 →